Randomized Phase Ii Study of Mehd7945A (Mehd) Vs Cetuximab (Cet) in >= 2Nd-Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck (Rmscchn) Progressive On/After Platinum-Based Chemotherapy (Ptct)
2008 ◽
Vol 26
(15_suppl)
◽
pp. 4546-4546
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 6051-6051
2013 ◽
Vol 49
(8)
◽
pp. 835-841
◽